Skip to content

Insider · CIK 0001311404

Jeffrey A Rona

directorofficer

Files at SANW (S&W Seed Co), OVID (Ovid Therapeutics Inc.). First filing Mar 2, 2026, latest Mar 2, 2026.

Jeffrey A Rona files SEC Form 4 as director and officer at OVID (Ovid Therapeutics Inc.), and also at SANW (S&W Seed Co). Since Mar 2, 2026, Jeffrey A Rona has reported 0 open-market buys worth $0 and 1 open-market sell worth $12k, the latest filed on Mar 2, 2026.

A track record needs three past buys with six months of prices behind them; Jeffrey A Rona has 0, so none is measured yet.

The newest scored trade: sold $12k of OVID on Feb 23, 2026, filed Mar 2, 2026, scored 23 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $12k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $12k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

OVID: Ovid Therapeutics Inc.

OVIDOct 9, 2026 · close 2.46

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
23Weak
OVIDsell 2
Ovid Therapeutics Inc.
$12k
8,541 shares
-9%+469% from low-21% from high

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 23, 2026OVID
Ovid Therapeutics Inc.
SOpen-market sale
Common Stock
-8,541$1.45$12k88,188Mar 2, 2026
Feb 26, 2026OVID
Ovid Therapeutics Inc.
AGrant or award
Common Stock
+68,125$0.00$0156,313Mar 2, 2026
Feb 26, 2026OVID
Ovid Therapeutics Inc.
AGrant or award
Employee Stock Option (Right to Buy)derivative
+408,750$0.00$0408,750Mar 2, 2026
Dec 17, 2024SANW
S&W Seed Co
AGrant or award
Common Stock
+12,725$0.00$020,700Dec 19, 2024

Questions about Jeffrey A Rona

Answered from the filings on this page, as of the latest one.

Is Jeffrey A Rona buying or selling?

In the last 12 months Jeffrey A Rona reported 0 open-market buys worth $0 and 1 open-market sell worth $12k on SEC Form 4; the latest was sold $12k of OVID on Feb 23, 2026. Grants, option exercises and tax withholding are not counted.

How did Jeffrey A Rona's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey A Rona has 0.

Where does Jeffrey A Rona file Form 4?

Jeffrey A Rona has filed Form 4 at OVID (Ovid Therapeutics Inc.) as CBFO; SANW (S&W Seed Co). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.